DK157078C - Fremgangsmaade til fremstilling af 2-hydroxyethylidencyaneddikesyreanilid-derivater - Google Patents

Fremgangsmaade til fremstilling af 2-hydroxyethylidencyaneddikesyreanilid-derivater

Info

Publication number
DK157078C
DK157078C DK248476A DK248476A DK157078C DK 157078 C DK157078 C DK 157078C DK 248476 A DK248476 A DK 248476A DK 248476 A DK248476 A DK 248476A DK 157078 C DK157078 C DK 157078C
Authority
DK
Denmark
Prior art keywords
hydroxyethylideencyanedic
ananilide
acetic
derivatives
preparing
Prior art date
Application number
DK248476A
Other languages
English (en)
Other versions
DK248476A (da
DK157078B (da
Inventor
Hartmut Ertel
Guenther Heubach
Erhard Wolf
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK248476A publication Critical patent/DK248476A/da
Publication of DK157078B publication Critical patent/DK157078B/da
Application granted granted Critical
Publication of DK157078C publication Critical patent/DK157078C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK248476A 1975-06-05 1976-06-04 Fremgangsmaade til fremstilling af 2-hydroxyethylidencyaneddikesyreanilid-derivater DK157078C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2524929 1975-06-05
DE2524929A DE2524929C3 (de) 1975-06-05 1975-06-05 2-Hydroxyäthylidencyanessigsäureanilide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel

Publications (3)

Publication Number Publication Date
DK248476A DK248476A (da) 1976-12-06
DK157078B DK157078B (da) 1989-11-06
DK157078C true DK157078C (da) 1990-04-09

Family

ID=5948272

Family Applications (1)

Application Number Title Priority Date Filing Date
DK248476A DK157078C (da) 1975-06-05 1976-06-04 Fremgangsmaade til fremstilling af 2-hydroxyethylidencyaneddikesyreanilid-derivater

Country Status (15)

Country Link
US (1) US4061767A (da)
JP (1) JPS6032620B2 (da)
AT (1) AT343641B (da)
BE (1) BE842688A (da)
CA (1) CA1082202A (da)
CH (1) CH627444A5 (da)
DE (1) DE2524929C3 (da)
DK (1) DK157078C (da)
FR (1) FR2313031A1 (da)
GB (1) GB1555555A (da)
IE (1) IE43004B1 (da)
IT (1) IT1063593B (da)
LU (1) LU75075A1 (da)
MX (1) MX3170E (da)
NL (2) NL186239C (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55500866A (da) * 1978-11-03 1980-10-30
US4173650A (en) * 1978-11-03 1979-11-06 American Cyanamid Company Cis-2-benzoyl-3-hydroxy-2-alkenonitriles as anti-inflammatory agents
US4181677A (en) * 1978-12-13 1980-01-01 American Cyanamid Company 2-Benzoyl-3-alkoxy-2-alkenonitriles
US4259256A (en) * 1978-12-13 1981-03-31 American Cyanamid Company 2-Benzoyl-3-dimethylamino-2-alkenonitriles
PT71367A (en) * 1979-06-11 1980-07-01 Ciba Geigy Ag Process for preparing alphacarbamoyl-pyrrolpropionitriles
US4256759A (en) * 1979-06-11 1981-03-17 Ciba-Geigy Corporation Alphacarbamoyl-pyrrolpropionitriles
US4277420A (en) * 1979-09-24 1981-07-07 Monsanto Company Ephedrine and pseudoephedrine precursors
US4254048A (en) * 1979-12-17 1981-03-03 American Cyanamid Company Substituted phenyl alkylidene acetoacetonitriles
US4254047A (en) * 1979-12-17 1981-03-03 American Cyanamid Company Substituted phenyl-2-cyano-2-thioalkenoic acid esters
US4254049A (en) * 1979-12-17 1981-03-03 American Cyanamid Company Substituted phenyl-2-cyano-2-alkenoic acid esters
US4435407A (en) 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
US4644010A (en) * 1982-09-28 1987-02-17 Ciba-Geigy Corporation Certain β-oxo-α-carbamoylpyrrolepropionitriles
DE3247454A1 (de) * 1982-12-22 1984-06-28 Laboratorios Bago S.A., Buenos Aires Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
GB8619433D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
US4888357A (en) * 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
US4975462A (en) * 1988-07-29 1990-12-04 Bristol-Myers Company Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
DD297328A5 (de) 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5034410A (en) * 1989-10-11 1991-07-23 Syntex (U.S.A.) Inc. Anthelmintically active benzenepropanamide derivatives
ZA913762B (en) 1990-05-18 1992-01-29 Hoechst Ag Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides,pharmaceuticals containing these compounds and their use
HU222234B1 (hu) * 1990-05-18 2003-05-28 Aventis Pharma Deutschland Gmbh. Eljárás izoxazol-4-karbonsav-amidok és hidroxi-alkilidén-cián-ecetsav-amidok, a vegyületeket tartalmazó gyógyászati készítmények és az ismert vegyületeket tartalmazó rákellenes hatású gyógyszerkészítmények előállítására
ATE141950T1 (de) * 1990-12-24 1996-09-15 Hoechst Ag Verfahren zur acylierung von alkoholen mit einem immobilisierten pseudomonas-lipase
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide
ATE128353T1 (de) * 1991-10-23 1995-10-15 Hoechst Ag N-phenyl-2-cyano-3-hydroxycrotonsäureamidderiva e und deren verwendung als arzneimittel mit immunmodulatorischer eigenschaft.
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
GB9209330D0 (en) * 1992-04-30 1992-06-17 Roussel Lab Ltd Chemical compounds
GB9300083D0 (en) 1993-01-05 1993-03-03 Roussel Lab Ltd Chemical compounds
TW314467B (da) * 1993-03-31 1997-09-01 Hoechst Ag
RU2139092C1 (ru) * 1993-06-03 1999-10-10 Терапьютик Антибодиз Инк. Фрагменты антител в терапии
GB9313365D0 (en) * 1993-06-29 1993-08-11 Roussel Lab Ltd Chemical compounds
GB9322781D0 (en) * 1993-11-04 1993-12-22 Roussel Lab Ltd Aromatic amides
LT3589B (en) 1993-11-30 1995-12-27 Hoechst Ag Using of known combination for treatment of rejection reaction by transplantation of organs
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
ATE207065T1 (de) 1997-08-08 2001-11-15 Aventis Pharma Gmbh Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid
US6355678B1 (en) 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
US20050255071A1 (en) * 1998-12-10 2005-11-17 Aventis Pharma Deutschland Gmbh Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
GB0123571D0 (en) * 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
DE10132308A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Kombinationspräparat zur Therapie von immunologischen Erkrankungen
MXPA04000224A (es) 2001-07-10 2005-07-25 4Sc Ag Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos.
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
RU2367650C2 (ru) 2002-12-23 2009-09-20 4Ск Аг Циклоалкендикарбоновые кислоты как противовоспалительные, иммуномодулирующие и антипролиферативные средства
UA108760C2 (uk) 2010-07-01 2015-06-10 Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби
WO2015077535A2 (en) 2013-11-22 2015-05-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases
IL307422A (en) 2018-03-16 2023-12-01 Immunic Ag Polymorphs of the calcium salts that suppress dihydrouroatate dehydrogenase, and methods for their production
US11376232B2 (en) 2020-04-21 2022-07-05 Immunic Ag Vidofludimus for use in the treatment or prevention of viral diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2288863A (en) * 1940-02-27 1942-07-07 Hoffmann La Roche Process for the manufacture of substituted amides of 3,5-dimethylisoxazole-4-carboxylic acid
BE506549A (da) * 1950-10-19

Also Published As

Publication number Publication date
GB1555555A (en) 1979-11-14
LU75075A1 (da) 1977-03-07
DE2524929B2 (de) 1980-01-31
JPS6032620B2 (ja) 1985-07-29
FR2313031B1 (da) 1979-10-12
DK248476A (da) 1976-12-06
FR2313031A1 (fr) 1976-12-31
NL7605845A (en) 1976-12-07
DE2524929A1 (de) 1976-12-16
CH627444A5 (de) 1982-01-15
JPS527929A (en) 1977-01-21
IE43004B1 (en) 1980-12-03
ATA413576A (de) 1977-10-15
IT1063593B (it) 1985-02-11
NL186239B (nl)
CA1082202A (en) 1980-07-22
BE842688A (fr) 1976-12-08
DK157078B (da) 1989-11-06
US4061767A (en) 1977-12-06
DE2524929C3 (de) 1980-10-09
AT343641B (de) 1978-06-12
MX3170E (es) 1980-06-05
IE43004L (en) 1976-12-05
NL186239C (nl) 1990-10-16

Similar Documents

Publication Publication Date Title
DK157078C (da) Fremgangsmaade til fremstilling af 2-hydroxyethylidencyaneddikesyreanilid-derivater
DK494876A (da) Fremgangsmade til fremstilling af piperidinderivater
DK365176A (da) Fremgangsmade til fremstilling af pyrrolidinderivater
DK518176A (da) Fremgangsmade til fremstilling af polyprenylderivater
DK145228C (da) Analogifremgangsmaade til fremstilling af 3-amino-4-deoxo-4-iminorifamycinderivater
DK562376A (da) Fremgangsmade til fremstilling af ergolinderivater
DK462376A (da) Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater
DK155002C (da) Analogifremgangsmaade til fremstilling af salicylanilidderivater
DK144476C (da) Fremgangsmaade til fremstilling af amoxicillin-trihydrat
DK360576A (da) Fremgangsmade til fremstilling af pyridinderivater
DK324776A (da) Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler
DK431176A (da) Fremgangsmade til fremstilling af hypolipemiske phenyleddikesyrederivater
DK494976A (da) Fremgangsmade til fremstilling af purinderivater
DK97376A (da) Fremgangsmade til fremstilling af histidinderivater
DK305876A (da) Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid
DK155598C (da) Fremgangsmaade til fremstilling af ethylchlorthioformiat
DK143281C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK143137C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK365276A (da) Fremgangsmade til fremstilling af pyrrolinderivater
DK140172C (da) Fremgangsmaade til fremstilling af 5-androsten-17-on-derivater
DK154888C (da) Analogifremgangsmaade til fremstilling af 6-substituerede-6-methoxypenicillansyrederivater
DK158316C (da) Fremgangsmaade til fremstilling af 3-substituerede 7-amino-3-cephem-4-carboxylsyrederivater
DK27976A (da) Fremgangsmade til fremstilling af diphenyletherderivater
DK319276A (da) Fremgangsmade til femstilling af nitroquinolinderivater
DK140576A (da) Fremgangsmade til fremstilling af 21-hydroxy-16-pregnen-20-on-derivater